CEO: William K. Heiden

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.


Key numbers

Market Capitalization:317114600
Shares Outstanding: 33916000
Float: 29167014
Next Earning Date:2020-02-13
TTm EPS: -8.3845
TTm Dividend Rate:
200 days moving average:10.76
50 days moving average: 11.28
One day percent Change: -2.91



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,